Back to Agenda
NCA Showcase: Brexit Implications for the EU27 Network and Decentralised Activities
Session Chair(s)
Christa Wirthumer-Hoche, PhD
Chair, EMA Management Board, Head
Austrian Medicines & Medical Devices Agency (AGES), Austria
This session gives the floor to the National Competent Authorities (NCA) to discuss their local progress, burning topics, and stakeholder engagement regarding Brexit.
Speaker(s)
Brexit Implications for the HMA Multi-Annual Work Programme
Christa Wirthumer-Hoche, PhD
Austrian Medicines & Medical Devices Agency (AGES), Austria
Chair, EMA Management Board, Head
HMA Brexit Task Force
Hugo Hurts
Medicines Evaluation Board (MEB), Netherlands
Chair HMA Brexit Task Force; Executive Director
Focus on MRP/DCP
Laura Oliveira Santamaria, MPharm
AEMPS, Spain
Head of RRAA Division, Human Medicines Department
How is Industry Preparing?
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Strengthening and Optimisation of Regulatory Procedures
Stan A van Belkum, MSc
Medicines Evaluation Board, Netherlands
Deputy Director
Have an account?